Steering commitee
The board
Our members
Igor Aurer
KroHem – Croatia
University of Zagreb
Zagreb – Croatia
KroHem
Martin Dreyling
European MCL Network – Germany
Klinikum der Universität München – Medizinische Klinik III
Münich – Germany
Tarec El Galaly
NLG – Denmark
Aalborg University Hospital
Aalborg – Denmark
Andres Ferreri
FIL – ITALY
San Raffaele Scientific Institute
Milan – Italy
FIL
Christopher Fox
NHS - UK
University of Nottingham
Nottingham – UK
NHS
Ingrid Glimelius
NLG – SWEDEN
Karolinska Institutet – Uppsala University Hospital
Uppsala – Sweden
NLG
Marie José Kersten
HOVON – NETHERLAND
AMC
Amsterdam – Netherland
HOVON
Irina Kryachok
UKRAINE
National Cancer Institute
Kiev – Ukraine
Sirpa Leppä
NLG - Finland
Dept Oncology Helsinki University Central Hospital Helsinki
Helsinki – Finland
NLG
Armando Lopez Guillermo
GELTAMO - Spain
Hospital Clínic Barcelona
Barcelone – Spain
GELTAMO
Stefano Luminari
FIL - ITALY
University of Modena and Reggio Emilia
Modène – Italy
FIL
Joanna Romejko Jarosinska
PLRG - Poland
Maria Skłodowska-Curie National Research Institute of Oncology
Varsovie – Poland
PLRG
Marek Trněný
Czech Republic
Charles University, General Hospital
Prague – Czech Republic
Emanuele Zucca
IELSG - Switzerland
IOSI – Oncology Institute of Southern Switzerland
Bellinzona – Switzerland
IELSG
Our honorary members
Dolores Caballero
GELTAMO - SPAIN
Complejo Asistencial Universitario de Salamanca
Salamanca – Spain
GELTAMO
Massimo Federico
FIL – Italy
University of Modena and Reggio Emilia Centro Oncologico Modenese
Modena – Italy
FIL
Eva Kimby
NLG - SWEDEN
Karolinska Institute
Stockholm – Sweden
NLG
Hervé Tilly
LYSA - France
Centre Henri Becquerel
Rouen – France
LYSA
Our private partners
Our partners actively participate in the funding of ELI activities, in particular the Thematic Workshops and the Lymphoma Hub.
Our institutional partners
Our institutional partners have enabled ELI to establish itself on the Lyon-Sud Hospital site, within the CENS-ELI building:
Patient
groups
ELI initiated a rapprochement with the Lymphoma Coalition Europe in 2017 to involve them in the life of the Institute and to share the Association’s reports and observations with its community.
Their representatives are invited to the Workshop and participate in the reflection on the missions and projects of ELI.